Jpmorgan Chase & CO Accolade, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Accolade, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 55,019 shares of ACCD stock, worth $194,767. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,019
Previous 2,957,326 98.14%
Holding current value
$194,767
Previous $10.6 Million 98.01%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
SELL
$3.4 - $4.42 $9.87 Million - $12.8 Million
-2,902,307 Reduced 98.14%
55,019 $211,000
Q3 2024

Nov 08, 2024
SELL
$3.4 - $4.42 $9.87 Million - $12.8 Million
-2,902,307 Reduced 98.14%
55,019 $211,000
Q2 2024

Dec 26, 2024
BUY
$3.58 - $10.13 $10.4 Million - $29.4 Million
2,902,307 Added 5275.1%
2,957,326 $10.6 Million
Q2 2024

Aug 12, 2024
SELL
$3.58 - $10.13 $8.5 Million - $24 Million
-2,373,993 Reduced 44.53%
2,957,326 $10.6 Million
Q1 2024

Dec 26, 2024
BUY
$9.22 - $15.02 $48.6 Million - $79.3 Million
5,276,300 Added 9589.96%
5,331,319 $55.9 Million
Q1 2024

May 10, 2024
SELL
$9.22 - $15.02 $9.95 Million - $16.2 Million
-1,079,058 Reduced 16.83%
5,331,319 $55.9 Million
Q4 2023

Dec 26, 2024
BUY
$6.5 - $12.85 $41.3 Million - $81.7 Million
6,355,358 Added 11551.21%
6,410,377 $77 Million
Q4 2023

Feb 12, 2024
SELL
$6.5 - $12.85 $1.12 Million - $2.21 Million
-171,714 Reduced 2.61%
6,410,377 $77 Million
Q3 2023

Nov 14, 2023
SELL
$10.45 - $15.02 $170,847 - $245,561
-16,349 Reduced 0.25%
6,582,091 $69.6 Million
Q2 2023

Aug 11, 2023
BUY
$10.52 - $16.06 $7.42 Million - $11.3 Million
705,383 Added 11.97%
6,598,440 $88.9 Million
Q1 2023

May 18, 2023
BUY
$7.32 - $14.38 $373,005 - $732,761
50,957 Added 0.87%
5,893,057 $84.7 Million
Q1 2023

May 11, 2023
BUY
$7.32 - $14.38 $4.72 Million - $9.27 Million
644,953 Added 12.41%
5,842,100 $84 Million
Q4 2022

Feb 13, 2023
SELL
$7.19 - $13.16 $5.41 Million - $9.89 Million
-751,865 Reduced 12.64%
5,197,147 $40.5 Million
Q3 2022

Nov 14, 2022
SELL
$0.0 - $12.8 $0 - $942,912
-73,665 Reduced 1.22%
5,949,012 $67.9 Million
Q2 2022

Aug 11, 2022
BUY
$5.28 - $18.9 $12.8 Million - $46 Million
2,431,956 Added 67.73%
6,022,677 $44.6 Million
Q1 2022

May 11, 2022
BUY
$12.92 - $27.18 $8.73 Million - $18.4 Million
675,881 Added 23.19%
3,590,721 $63.1 Million
Q4 2021

Feb 10, 2022
BUY
$21.96 - $42.69 $35.5 Million - $69 Million
1,615,620 Added 124.35%
2,914,840 $76.8 Million
Q3 2021

Nov 12, 2021
BUY
$41.3 - $54.56 $53.7 Million - $70.9 Million
1,299,220 New
1,299,220 $54.8 Million

Others Institutions Holding ACCD

# of Institutions
171
Shares Held
67.6M
Call Options Held
181K
Put Options Held
1.66M
View Full List

About Accolade, Inc.

ACCD Quotes by TradingView
  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $255M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email